Gastroparesis Trial, Recruiting NCT05846802 Sponsor: Johns Hopkins Bloomberg School of Public Health Condition: Gastroparesis
Back to Gastroparesis

Gastroparesis Trial, Recruiting

NCT05846802
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older at the time of your first screening visit
  • You have had symptoms of gastroparesis (delayed stomach emptying) and/or functional dyspepsia (stomach discomfort without a clear cause) for at least 12 weeks, which may include nausea, vomiting, feeling full quickly, feeling full after eating, stomach pain, or stomach burning
  • You have had a specific stomach-emptying scan (using an egg-based meal, or a similar alternative) completed within the last 9 months
  • You have had a camera exam of your upper digestive tract (like an endoscopy) or an imaging scan of your upper digestive system within the last 5 years, with normal or non-concerning results

Who may not be able to join:

  • You use strong prescription pain medications (opioids/narcotics) more than three days per week
  • You have a blockage in your stomach or intestines confirmed by medical testing
  • You have active inflammatory bowel disease (such as Crohn's disease or ulcerative colitis)
  • You have been diagnosed with a condition involving excess immune cells (eosinophils) affecting your stomach, intestines, or esophagus
  • You have a neurological condition affecting your brain or nervous system that could cause nausea or vomiting (confirm with trial site)
  • You have serious kidney problems, including kidney failure or being on dialysis
  • You have serious liver disease or acute liver failure (confirm with trial site)
  • You have a known pancreas disorder confirmed by imaging or testing
  • You have previously had surgery on your stomach or esophagus, including gastric bypass, gastric sleeve, stomach removal (partial or full), or other related procedures
  • You have any other condition that, in the doctor's opinion, could explain your symptoms or make it difficult to participate
  • You are currently pregnant (a pregnancy test will be done before the stomach-emptying scan)
  • You are unable to complete the stomach-emptying scan for any reason, including an allergy to eggs
  • You are unable or unwilling to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jay Pasricha, MD, Mayo Clinic

Phone: 4435024165

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Johns Hopkins Bloomberg School of Public Health
Registry
ClinicalTrials.gov
Start date
20 September 2024
Est. completion
30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Measure of symptom severity of gastroparesis and functional dyspepsia using the change in total score from the Patient Assessment of Upper Gastrointestinal Disorders Symptoms (PAGI SYM) from baseline to 48 weeks.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov